-
Risk Factors, Pathogen Distribution, and Treatment Strategies for Mortality in Elderly Patients with Pulmonary Bacterial Infections
03 Feb 2026 15:27 GMT
… intersection of aging and drug-resistant infections as a … outlined in the World Medical Assembly Declaration of Helsinki … 47;ritonavir was the sole agent employed for the treatment of … ,68 A randomized controlled trial demonstrates that nutrition interventions …
-
Metformin Shows Promise as a Preventive Treatment for Long COVID
30 Jan 2026 12:27 GMT
… paper, the University of Minnesota Medical School research team provides information … adults and across multiple clinical trials and high-quality electronic … also given FDA-approved treatments of SARS- COV-2 (including nirmatrelvir-ritonavir, molnupiravir …
-
Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
27 Jan 2026 08:31 GMT
… to previously known Ritonavir forms, advancing the understanding of pharmaceutical polymorphism.
WEST … our clients.
#SolidStateChemistry #Polymorphism #MicroED #DrugDevelopment #Crystallography #ImprovedPharma #Rigaku #VardaSpace
About …
-
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
26 Jan 2026 13:30 GMT
… comparator trial versus PAXLOVID® (nirmatrelvir/ritonavir), evaluated … integrates antiviral drug development, medical intelligence and regulatory … as a ritonavir-independent COVID-19 treatment, targeting … of Traws’ clinical trials, including when Traws …
-
Ensitrelvir Shows Promise as Effective COVID-19 Antiviral in Phase 2 Trial
22 Jan 2026 18:34 GMT
… ensitrelvir, ritonavir-boosted nirmatrelvir (both for five days), or no treatment) was … 61–104) than no study medication. Nirmatrelvir and ensitrelvir exhibited the … , phase 2, randomised, controlled, adaptive trial. The Lancet Infectious Diseases. https …
-
Pfizer's Covid pill Paxlovid wins expanded MFDS nod for severe renal impairment patients
16 Jan 2026 03:29 GMT
… of treatment, followed by nirmatrelvir 150 mg and ritonavir 100 … five. On dialysis days, medication should be taken after dialysis … ;ritonavir once daily on days two to five maintained drug … observed in placebo-controlled trials.1
After receiving emergency …
-
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
13 Jan 2026 12:00 GMT
… consistent with prior clinical trial and real-world experience … Traws integrates antiviral drug development, medical intelligence and regulatory … as a ritonavir-independent COVID treatment, targeting the … FDA; the success and timing of Traws’ clinical trials …
-
<![CDATA[Hepatitis D Coinfection: What Pharmacists Need to Know About Emerging Treatment Options]]>
05 Jan 2026 21:15 GMT
… treatment granted conditional marketing authorization by the European Medicines … FDA in 2024, which helps expedite the development and review of drugs … in combination with ritonavir 100 mg and … Elebsiran (VIR-2218; Vir Biotechnology, Alnylam) and Tobevibart ( …
-
Considerations and strategies for pharmaceutical companies before the UPC
05 Jan 2026 19:13 GMT
… chemotherapy drug cabazitaxel), the pace is starting to pick up. Enanta Pharmaceuticals … -19 antiviral, Paxlovid (nirmatrelvir and ritonavir combination), and for the first … Medical Sciences in respect of its patent for the Covid-19 treatment …
-
Drug Repurposing as an Effective Drug Discovery Strategy: A Critical Review
30 Dec 2025 17:11 GMT
… trials including the RECOVERY trial demonstrated no clinical benefit, leading the FDA … new pharmaceutical applications for drugs already … treatment of depressive disorders in patients showing inadequate response to standard antidepressant medications …
About
© 1995-2026